Forte Biosciences Inc — Quarterly Financial Statistics (NASDAQ:FBRX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -10.01 M-10.36 M-10.06 M-14 M-16.47 M -50.88 M Cash from investing activities -35.99 M36.29 M0-55 K0 36.23 M Cash from financing activities 51.88 M-2.32 M70.35 M1.32 M9 000 69.36 M Free cash flow -10.04 M-10.42 M-10.06 M-14.05 M-16.47 M -51 M

Haberler

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts

Forte Biosciences, 150 milyon dolarlık hisse arzını fiyatladı

Forte Biosciences halka hisse arz ediyor

Guggenheim, veri öncesi Forte Biosciences hisse notunu korudu

Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know

Micron, Insmed among market cap stock movers on Thursday

Evercore ISI, Forte Biosciences hissesi için Outperform tavsiyesi ile takibe başladı

Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating

Guggenheim initiates Forte Biosciences stock with Buy rating on autoimmune therapy potential

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data - TipRanks.com